Log In
    Company Data

    Inhibikase Therapeutics Inc.

    Biotechnology
    Healthcare
    Advanced Market Data
    Ticker
    IKT
    Current Price
    $2.31 -4.15%
    Market Cap
    $322.3M
    Price Target
    Refer to Report
    Volume
    329.9K
    52wk Range
    $1.33 - $2.54
    Advanced Market Data

    Overview

    Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson’s disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.

    Other Considerations

    Nutriband Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Nutriband Inc.
    Nutriband Inc.
    NTRB (NSC)
    $4.367
    $4.46(-2.09%)
    53.1M
    25.8K
    $2.8 - $8.6259
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Greenwich LifeSciences Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Greenwich LifeSciences Inc.
    Greenwich LifeSciences Inc.
    GLSI (NSC)
    $14.95
    $15.67(-4.59%)
    219.4M
    169.5K
    $7.78 - $34.1
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Unicycive Therapeutics Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Unicycive Therapeutics Inc.
    Unicycive Therapeutics Inc.
    UNCY (NSC)
    $5.2
    $5.27(-1.23%)
    144.8M
    574.2K
    $3.71 - $8.74
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Cadrenal Therapeutics Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Cadrenal Therapeutics Inc.
    Cadrenal Therapeutics Inc.
    CVKD (NSC)
    $1.75
    $1.54(13.64%)
    6.2M
    21.3M
    $1.49 - $14.64
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    The Oncology Institute Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    The Oncology Institute Inc.
    The Oncology Institute Inc.
    TOI (NSC)
    180.5K
    $2.32 - $6.67
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    iCoreConnect Inc
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    iCoreConnect Inc
    iCoreConnect Inc
    ICCT (OTCQB)
    $0.0011
    5.4K
    42.5K
    $1.0E-6 - $0.22
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    LakeShore Biopharma Co. Ltd.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    LakeShore Biopharma Co. Ltd.
    LakeShore Biopharma Co. Ltd.
    LSB (NSC)
    $0.627
    25.8M
    2.4M
    $0.5743 - $0.8799
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    MAIA Biotechnology Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    MAIA Biotechnology Inc.
    MAIA Biotechnology Inc.
    MAIA (AMX)
    $1.31
    $1.33(-1.5%)
    79.7M
    258.5K
    $0.87 - $3.19
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    ChitogenX Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    ChitogenX Inc.
    ChitogenX Inc.
    CHNXF (OTCQB)
    $0.00755
    627.6K
    $0.0011 - $0.00755
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Baudax Bio Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Baudax Bio Inc.
    Baudax Bio Inc.
    BXRX (Nasdaq)
    2.6M
    $0.0137 - $3.4699
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In